DXCM as of Nov 1 · 23:19 ET
DXCMNasdaqSurgical & Medical Instruments & Apparatus
DexCom Inc · Brief
Next report
101 days
Feb 11 · after closeest.Q4 FY26
Expected move
No implied move.
4 of 8≥ implied
- avg implied
- ±8.7%
- avg realized
- ±8.9%
Feb 13 '25±7.8%▲+5.92%×0.76
May 1 '25±9.4%▲+16.17%×1.72
Jul 30 '25±8.4%▼−9.31%×1.11
Oct 30 '25±12.6%▼−14.63%×1.16
Feb 12 '26±9.3%▲+7.59%×0.81
Q1 FY26±8.9%▲+3.02%×0.34
Q2 FY26±6.2%▲+11.95%×1.92
Q3 FY26±6.7%▲+2.95%×0.44
quarterimplied−20%0+20%realized×
Q3 FY26±6.7%▲+2.95%×0.44
Q2 FY26±6.2%▲+11.95%×1.92
Q1 FY26±8.9%▲+3.02%×0.34
Feb '26±9.3%▲+7.59%×0.81
Oct '25±12.6%▼−14.63%×1.16
Jul '25±8.4%▼−9.31%×1.11
2 older reports
May '25±9.4%▲+16.17%×1.72
Feb '25±7.8%▲+5.92%×0.76
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close
Bull & bear
Feb 11 report · est.—
Linked exposure
DXCM report sessionSuppliers 1
Customers 1
× = co-movement · max 501dSource: SEC filings · market data
Your note
privateThesis 0 · Decisions 0 · Observations 0
No thesis.